Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders.

Health services Manufacturing Pharma

Investments

07 November 2025

Artios Pharma (company)

Health services Manufacturing Pharma

Total investments received (USD): 115m

Round value (USD): 115m

Round investors: Andera Partners EQT Partners Invus IP Group Merck Ventures Novartis Venture Fund Omega Funds Pfizer Venture Investments RA Capital Management Schroders SV Health Investors Avidity Partners TCGX Janus Henderson

Company: Artios Pharma

Industry: Health services Manufacturing Pharma

Related deals

OrganOx was acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo in a deal valued at approximately £1.5 billion

Health services Manufacturing

Secondary 14 July 2025

Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital.

Biotech Health services Manufacturing

Investments 07 June 2025

CellCentric raised $120m in Series C funding led by RA Capital Management, joined by Forbion, Avego Bioscience Capital, and BrightEdge.

Biotech Health services Manufacturing

Investments 09 May 2025

Menu

Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders.

Share:

Artios Pharma (company)

Related deals

OrganOx was acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo in a deal valued at approximately £1.5 billion

Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital.

CellCentric raised $120m in Series C funding led by RA Capital Management, joined by Forbion, Avego Bioscience Capital, and BrightEdge.

Sidebar

Verticals

Benelux

DACH

Nordics and Baltics

Western Europe